Synapticure Emphasizes Telehealth Role in Parkinson’s and Movement-Disorder Care

A LinkedIn post from Synapticure highlights the company’s involvement in an educational workshop focused on Parkinson’s disease and telehealth. The post notes that Synapticure’s Movement Disorders Director, Dr. Elizabeth Ferluga, is scheduled to speak at the APDA Georgia Chapter and Center for Movement Challenges event on Friday, March 13, in Sandy Springs, Ga.

According to the post, Dr. Ferluga will be joined by Dr. Cristina Pritchett of Emory School of Medicine for a discussion on how telehealth is expanding access to expert neurological care, mental health support, and wellness resources. The event is described as aimed at individuals navigating Parkinson’s who are seeking greater support in managing both physical and emotional aspects of the condition.

For investors, the post suggests Synapticure is positioning itself as an active participant in the telehealth and movement-disorder care ecosystem, with an emphasis on Parkinson’s disease. Visible engagement in clinical education and collaboration with academic partners such as Emory may reinforce the company’s credibility with patients, clinicians, and payers, which could support patient acquisition and long-term demand for its virtual neurology services.

The focus on mental health, wellness, and between-appointment support also points to a care model that extends beyond episodic visits, potentially increasing patient stickiness and recurring revenue opportunities. While the post does not provide financial metrics or product-specific details, the emphasis on expanding access via telehealth aligns with broader industry trends that favor scalable, virtual specialist care, which may be a positive indicator for Synapticure’s growth prospects if it can execute effectively and navigate reimbursement dynamics.